NCT00513162View on ClinicalTrials.gov

Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2012

Conditions
Neuroectodermal TumorBrain MetastasesAdvanced Cancer
Interventions
DRUG

Valproate

Starting Dose of 10 mg/kg By Mouth Daily

DRUG

Etoposide

25 - 50 mg/m\^2 By Mouth Daily

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00513162 - Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases | Biotech Hunter | Biotech Hunter